- Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinomaHoward L Kaufman
Tumor Immunology Laboratory, Division of Surgical Oncology, Columbia University, New York, NY, USA
J Transl Med 7:2. 2009..A modified vaccinia virus Ankara (MVA) encoding 5T4 was tested in combination with high-dose IL-2 to determine the safety, objective response rate and effect on humoral and cell-mediated immunity...
- Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreasW H Sherman
Division of Medical Oncology, Department of Medicine, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA
Oncology 60:316-21. 2001..To determine the clinical and laboratory response rate of a gemcitabine and docetaxel combination in human adenocarcinoma of the pancreas in vitro and in vivo...
- Sirolimus can reverse resistance to gemcitabine, capecitabine and docetaxel combination therapy in pancreatic cancerWilliam H Sherman
Columbia University, College Physicians and Surgeons, New York, NY, USA
JOP 10:393-5. 2009..If resistance can be reversed or prevented, the chemotherapeutic benefit may be prolonged...